Patent details

91851 Product Name: "Aztréonam , pas en composition avec l'arginine, ou un sel pharmaceutiquement acceptable de l'aztréonam autre qu'un sel d'origine en particulier l'aztréonam lysine"

Basic Information

Publication number:
91851
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019915230
Legal Status:
Expired
Application number:
91851
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/09/543/001 - Cayston-aztréonam
Marketing Authorization Type:
Marketing Authorization Date:
23/09/2009
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
03/08/2011
First Marketing Authorization date:
23/09/2009
Grant date:
03/10/2011
Activation date:
Publication date:
03/10/2011
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/09/2024
SPC Extension Expiration:
23/09/2024
Rejection date:
Withdrawal date:

Owner

From:
03/08/2011
 
 

Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/08/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
MONTGOMERY Alan, Bruce
Address:
United States (US)

Publication

Bulletin

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/12/2023
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
430 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
03/01/2019 Outgoing Correspondence 1
03/01/2019 Publication 1
18/07/2016 Incoming Correspondence (Post) 2